This study evaluate the additional effect of adding chemotherapy prior to resection of a
pancreatic head malignancy. The patients will be randomized into two groups; surgery first
(control group) and neoadjuvant chemotherapy (intervention). Primary endpoint is overall
survival after resection
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Oslo University Hospital
Collaborators:
Haukeland University Hospital Helse Stavanger HF St. Olavs Hospital University Hospital of North Norway